Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients
Famotidine has been posited as a potential treatment for coronavirus disease 2019. The study population was COVID-19 hospitalized patients aged 18 yea...
Colorectal Cancer Screening With Repeated Fecal Immunochemical Test Versus Sigmoidoscopy: Baseline Results From a Randomized Trial
The effectiveness of sigmoidoscopy and fecal immunochemical testing (FIT) for colorectal cancer screening is unknown. Colonoscopy was recommended afte...
Colonoscopist Performance and Colorectal Cancer Risk After Adenoma Removal to Stratify Surveillance: Two Nationwide Observational Studies
Colonoscopy surveillance after adenoma removal is an increasing burden in many countries. Surveillance recommendations consider characteristics of rem...
Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study
There is a medical need for highly effective, safe, and well-tolerated treatments for patients infected with hepatitis C virus (HCV) Eight patients ha...
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis
Irritable bowel syndrome (IBS) is one of the most common functional bowel disorders. Community prevalence appears to vary widely between different cou...
Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial
Outcomes were assessed at clinic discharge or 9 months after the initial visit. The primary outcome was a score of 4 or 5 on a 5-point Likert scale as...
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
Liver transplantation did not significantly increase the risk of death in patients with SARS-CoV-2 infection. Increased age and presence of comorbidit...
Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial
Lubiprostone was well tolerated and reduced the levels of liver enzymes in patients with NAFLD and constipation. The most common adverse event was dia...
Recent Posts
-
-
What Causes Sciatica | Dr. Kalyan Bommakanti
11 May 2022 -
